21 / 25
Page 49
Notes:
allied
academies
February 25-26, 2019 | Paris, France
13
th
World Cancer Congress
Journal of Medical Oncology and Therapeutics | Volume 4
Improved liver function and tumour marker after high dose intravenous vitamin C and Helxior SC
injections in a patient with Hepatocellular Carcinoma progressed after chemotherapy and radiation
Ehab Mohammed
Cairo University, Egypt
A
dvanced hepatocellular carcinoma is one of the most
aggressiveandpoorlycontrolledmalignancieswitha limited
survival time. Usually, patients with advanced and progressive
hepatocellular carcinoma develop deterioration of their liver
functions which can be a major cause of their mortality.
I am reporting a case of a 71 years old male patient with an
advanced hepatocellular carcinoma who had progression after
transhepatic chemoembolization and radiation therapy with
deterioration of liver function tests then after receiving high
dose intravenous vitamin C and subcutaneous Helixor, his liver
function returned to normal, and up to the moment of writing
this research, he is enjoying a normal liver functions and high
physical performance. Most important is that his tumour
marker (alfa fetoprotein) retrned normal after 6 months of his
Vitamin C and Helixor treatments.
The use of high dose intravenous vitamin C and Helixor
injections can improve the liver functions, and overall physical
performance in a patient with advanced and progressed
hepatocellular carcinoma and deteriorating liver function. Most
importantly, in this patient, his tumour marker was lowered to
a normal valuses after 6 months of tretament.
e:
ehabesmatf@yahoo.com